» Articles » PMID: 15528346

Augmentation of T Cell Levels and Responses Induced by Androgen Deprivation

Overview
Journal J Immunol
Date 2004 Nov 6
PMID 15528346
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Androgen has been implicated as a negative regulator of host immune function and a factor contributing to the gender dimorphism of autoimmunity. Conversely, androgen deprivation has been suggested to potentiate male host immunity. Studies have shown that removal of androgen in postpubertal male mice produces an increase in size and cellularity of primary and peripheral lymphoid organs, and enhances a variety of immune responses. Yet, few details are known about the effect of androgen removal on T cell-mediated immunity. In this study, we demonstrate two pronounced and independent alterations in T cell immunity that occur in response to androgen deprivation, provided by castration, in postpubertal male mice. First, we show that levels of T cells in peripheral lymphoid tissues of mice are increased by androgen deprivation. Second, T cells from these mice transiently proliferate more vigorously to TCR- and CD28-mediated costimulation as well as to Ag-specific activation. In addition, androgen deprivation accelerates normalization of host T and B cell levels following chemotherapy-induced lymphocyte depletion. Such alterations induced by androgen deprivation may have implications for enhancing immune responses to immunotherapy and for accelerating the recovery of the immune system following chemotherapy.

Citing Articles

Immunome profiling in prostate cancer: a guide for clinicians.

San-Jose Manso L, Alfranca A, Moreno-Perez I, Ruiz-Vico M, Velasco C, Toquero P Front Immunol. 2024; 15:1398109.

PMID: 39635522 PMC: 11614818. DOI: 10.3389/fimmu.2024.1398109.


Androgens in cervical cancer: Their role in epidemiology and biology.

Gu Y, Mu Q, Cheng D iScience. 2024; 27(7):110155.

PMID: 39021790 PMC: 11253156. DOI: 10.1016/j.isci.2024.110155.


Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using Y-NM600 in combination with androgen deprivation therapy in murine prostate tumors.

Muralidhar A, Hernandez R, Morris Z, Rojas H, Idrissou M, Weichert J J Immunother Cancer. 2024; 12(4).

PMID: 38663936 PMC: 11043705. DOI: 10.1136/jitc-2023-008760.


High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.

Zhang Y, Darville L, Hogue S, Hallanger Johnson J, Rose T, Kim Y Cancers (Basel). 2024; 16(6).

PMID: 38539486 PMC: 10968948. DOI: 10.3390/cancers16061152.


Current Understanding of Androgen Signaling in Prostatitis and its Treatment: A Review.

Cabeza M Curr Med Chem. 2024; 31(27):4249-4266.

PMID: 38243983 DOI: 10.2174/0109298673279207231228070533.